Oui, le tabagisme est associé à un risque accru de vascularite et d'autres maladies vasculaires.
TabagismeRisqueVascularite
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Vascularite du système nerveux central : Questions médicales les plus fréquentes",
"headline": "Vascularite du système nerveux central : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Vascularite du système nerveux central : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-06-09",
"dateModified": "2026-03-01",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Vascularite du système nerveux central"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Maladies auto-immunes du système nerveux",
"url": "https://questionsmedicales.fr/mesh/D020274",
"about": {
"@type": "MedicalCondition",
"name": "Maladies auto-immunes du système nerveux",
"code": {
"@type": "MedicalCode",
"code": "D020274",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C20.111.258"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Artérite à cellules géantes",
"alternateName": "Giant Cell Arteritis",
"url": "https://questionsmedicales.fr/mesh/D013700",
"about": {
"@type": "MedicalCondition",
"name": "Artérite à cellules géantes",
"code": {
"@type": "MedicalCode",
"code": "D013700",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C20.111.258.962.800"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Vascularite du système nerveux central",
"alternateName": "Vasculitis, Central Nervous System",
"code": {
"@type": "MedicalCode",
"code": "D020293",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Rula A Hajj-Ali",
"url": "https://questionsmedicales.fr/author/Rula%20A%20Hajj-Ali",
"affiliation": {
"@type": "Organization",
"name": "Cleveland Clinic Center for Vasculitis Care and Research, Cleveland Clinic, 9500 Euclid Avenue, A50, Cleveland, OH 44195, USA. Electronic address: HAJJALR@ccf.org."
}
},
{
"@type": "Person",
"name": "David S Younger",
"url": "https://questionsmedicales.fr/author/David%20S%20Younger",
"affiliation": {
"@type": "Organization",
"name": "Department of Neurology, Division of Neuro-Epidemiology, New York University School of Medicine, New York, NY, USA; School of Public Health, City University of New York, New York, NY, USA. Electronic address: youngd01@nyu.edu."
}
},
{
"@type": "Person",
"name": "Carlo Salvarani",
"url": "https://questionsmedicales.fr/author/Carlo%20Salvarani",
"affiliation": {
"@type": "Organization",
"name": "Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA; Rheumatology Division, Azienda USL-IRCCS di Reggio Emilia e Università di Modena e Reggio Emilia, Reggio Emilia, Italy. Electronic address: carlo.salvarani@ausl.re.it."
}
},
{
"@type": "Person",
"name": "Robert D Brown",
"url": "https://questionsmedicales.fr/author/Robert%20D%20Brown",
"affiliation": {
"@type": "Organization",
"name": "Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA."
}
},
{
"@type": "Person",
"name": "John Huston",
"url": "https://questionsmedicales.fr/author/John%20Huston",
"affiliation": {
"@type": "Organization",
"name": "Department of Radiology, Mayo Clinic, Rochester, Minnesota, USA."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Perivascular invasion of primary human glioblastoma cells in organotypic human brain slices: human cells migrating in human brain.",
"datePublished": "2023-07-25",
"url": "https://questionsmedicales.fr/article/37490233",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s11060-023-04349-9"
}
},
{
"@type": "ScholarlyArticle",
"name": "Human",
"datePublished": "2024-05-29",
"url": "https://questionsmedicales.fr/article/38807524",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1098/rsif.2024.0074"
}
},
{
"@type": "ScholarlyArticle",
"name": "On human-in-the-loop optimization of human-robot interaction.",
"datePublished": "2024-09-25",
"url": "https://questionsmedicales.fr/article/39322732",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41586-024-07697-2"
}
},
{
"@type": "ScholarlyArticle",
"name": "Development of a thermodynamics of human cognition and human culture.",
"datePublished": "2023-08-14",
"url": "https://questionsmedicales.fr/article/37573880",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1098/rsta.2022.0378"
}
},
{
"@type": "ScholarlyArticle",
"name": "Industry 5 and the Human in Human-Centric Manufacturing.",
"datePublished": "2023-07-14",
"url": "https://questionsmedicales.fr/article/37514710",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/s23146416"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Maladies du système immunitaire",
"item": "https://questionsmedicales.fr/mesh/D007154"
},
{
"@type": "ListItem",
"position": 3,
"name": "Maladies auto-immunes",
"item": "https://questionsmedicales.fr/mesh/D001327"
},
{
"@type": "ListItem",
"position": 4,
"name": "Maladies auto-immunes du système nerveux",
"item": "https://questionsmedicales.fr/mesh/D020274"
},
{
"@type": "ListItem",
"position": 5,
"name": "Vascularite du système nerveux central",
"item": "https://questionsmedicales.fr/mesh/D020293"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Vascularite du système nerveux central - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Vascularite du système nerveux central",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2026-05-17",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Vascularite du système nerveux central",
"description": "Comment diagnostiquer une vascularite du SNC ?\nQuels tests d'imagerie sont utilisés ?\nQuels marqueurs sanguins sont recherchés ?\nLa ponction lombaire est-elle nécessaire ?\nQuels symptômes orientent vers ce diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D020293?mesh_terms=Humans#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Vascularite du système nerveux central",
"description": "Quels sont les symptômes courants ?\nPeut-on avoir des symptômes psychiatriques ?\nLes symptômes varient-ils selon l'âge ?\nY a-t-il des signes d'AVC associés ?\nLes symptômes sont-ils toujours présents ?",
"url": "https://questionsmedicales.fr/mesh/D020293?mesh_terms=Humans#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Vascularite du système nerveux central",
"description": "Peut-on prévenir la vascularite du SNC ?\nLes vaccinations sont-elles utiles ?\nComment réduire les facteurs de risque ?\nLes contrôles médicaux réguliers sont-ils importants ?\nL'alimentation joue-t-elle un rôle ?",
"url": "https://questionsmedicales.fr/mesh/D020293?mesh_terms=Humans#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Vascularite du système nerveux central",
"description": "Quels traitements sont utilisés ?\nLes traitements sont-ils efficaces ?\nY a-t-il des effets secondaires des traitements ?\nDes traitements alternatifs existent-ils ?\nQuelle est la durée du traitement ?",
"url": "https://questionsmedicales.fr/mesh/D020293?mesh_terms=Humans#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Vascularite du système nerveux central",
"description": "Quelles sont les complications possibles ?\nLes complications sont-elles réversibles ?\nComment surveiller les complications ?\nLes complications affectent-elles la qualité de vie ?\nY a-t-il des risques de récidive ?",
"url": "https://questionsmedicales.fr/mesh/D020293?mesh_terms=Humans#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Vascularite du système nerveux central",
"description": "Quels sont les facteurs de risque connus ?\nL'âge influence-t-il le risque ?\nLe sexe joue-t-il un rôle ?\nLes antécédents médicaux influencent-ils le risque ?\nLe tabagisme est-il un facteur de risque ?",
"url": "https://questionsmedicales.fr/mesh/D020293?mesh_terms=Humans#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une vascularite du SNC ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'imagerie cérébrale, les analyses sanguines et parfois une biopsie."
}
},
{
"@type": "Question",
"name": "Quels tests d'imagerie sont utilisés ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'IRM et le scanner sont couramment utilisés pour visualiser les anomalies vasculaires."
}
},
{
"@type": "Question",
"name": "Quels marqueurs sanguins sont recherchés ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "On recherche des marqueurs d'inflammation comme la vitesse de sédimentation et les anticorps spécifiques."
}
},
{
"@type": "Question",
"name": "La ponction lombaire est-elle nécessaire ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut être effectuée pour analyser le liquide céphalorachidien et détecter des anomalies."
}
},
{
"@type": "Question",
"name": "Quels symptômes orientent vers ce diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des maux de tête, des troubles neurologiques et des signes d'AVC peuvent indiquer une vascularite."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des maux de tête, des troubles de la vision et des convulsions."
}
},
{
"@type": "Question",
"name": "Peut-on avoir des symptômes psychiatriques ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles de l'humeur et des changements de comportement peuvent survenir."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon l'âge ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent être plus sévères chez les personnes âgées en raison de comorbidités."
}
},
{
"@type": "Question",
"name": "Y a-t-il des signes d'AVC associés ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des signes tels que la faiblesse d'un côté du corps ou des difficultés à parler peuvent apparaître."
}
},
{
"@type": "Question",
"name": "Les symptômes sont-ils toujours présents ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les symptômes peuvent être intermittents et varier en intensité selon les poussées."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir la vascularite du SNC ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de méthode de prévention spécifique, mais un suivi médical régulier est conseillé."
}
},
{
"@type": "Question",
"name": "Les vaccinations sont-elles utiles ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines vaccinations peuvent réduire le risque d'infections qui pourraient déclencher une vascularite."
}
},
{
"@type": "Question",
"name": "Comment réduire les facteurs de risque ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Adopter un mode de vie sain, gérer le stress et éviter le tabac peuvent aider à réduire les risques."
}
},
{
"@type": "Question",
"name": "Les contrôles médicaux réguliers sont-ils importants ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des contrôles réguliers permettent de détecter précocement des signes de vascularite."
}
},
{
"@type": "Question",
"name": "L'alimentation joue-t-elle un rôle ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée peut soutenir le système immunitaire et réduire l'inflammation."
}
},
{
"@type": "Question",
"name": "Quels traitements sont utilisés ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les corticostéroïdes et les immunosuppresseurs sont souvent prescrits pour réduire l'inflammation."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils efficaces ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la plupart des patients répondent bien aux traitements, mais un suivi régulier est nécessaire."
}
},
{
"@type": "Question",
"name": "Y a-t-il des effets secondaires des traitements ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les effets secondaires peuvent inclure des infections, des troubles métaboliques et des problèmes digestifs."
}
},
{
"@type": "Question",
"name": "Des traitements alternatifs existent-ils ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des thérapies complémentaires comme la physiothérapie peuvent aider, mais ne remplacent pas les traitements médicaux."
}
},
{
"@type": "Question",
"name": "Quelle est la durée du traitement ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "La durée varie selon la gravité, mais peut aller de plusieurs mois à plusieurs années."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des AVC, des déficits neurologiques permanents et des troubles cognitifs."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles réversibles ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être réversibles, mais d'autres peuvent entraîner des séquelles permanentes."
}
},
{
"@type": "Question",
"name": "Comment surveiller les complications ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un suivi neurologique régulier et des examens d'imagerie permettent de surveiller les complications."
}
},
{
"@type": "Question",
"name": "Les complications affectent-elles la qualité de vie ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les complications peuvent significativement affecter la qualité de vie des patients."
}
},
{
"@type": "Question",
"name": "Y a-t-il des risques de récidive ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des récidives peuvent survenir, nécessitant une surveillance continue et un ajustement du traitement."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque connus ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent des maladies auto-immunes, des infections et des antécédents familiaux."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le risque augmente avec l'âge, surtout chez les personnes de plus de 50 ans."
}
},
{
"@type": "Question",
"name": "Le sexe joue-t-il un rôle ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les femmes sont plus souvent touchées par certaines formes de vascularite que les hommes."
}
},
{
"@type": "Question",
"name": "Les antécédents médicaux influencent-ils le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents de maladies inflammatoires ou auto-immunes augmentent le risque."
}
},
{
"@type": "Question",
"name": "Le tabagisme est-il un facteur de risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme est associé à un risque accru de vascularite et d'autres maladies vasculaires."
}
}
]
}
]
}
Cleveland Clinic Center for Vasculitis Care and Research, Cleveland Clinic, 9500 Euclid Avenue, A50, Cleveland, OH 44195, USA. Electronic address: HAJJALR@ccf.org.
Publications dans "Vascularite du système nerveux central" :
Department of Neurology, Division of Neuro-Epidemiology, New York University School of Medicine, New York, NY, USA; School of Public Health, City University of New York, New York, NY, USA. Electronic address: youngd01@nyu.edu.
Publications dans "Vascularite du système nerveux central" :
Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA; Rheumatology Division, Azienda USL-IRCCS di Reggio Emilia e Università di Modena e Reggio Emilia, Reggio Emilia, Italy. Electronic address: carlo.salvarani@ausl.re.it.
Publications dans "Vascularite du système nerveux central" :
Department of Advanced Medical and Surgical Sciences (DAMSS), University of Campania "Luigi Vanvitelli", Piazza L. Miraglia 2, 80138, Naples, Italy.
Clinical Department of Laboratory Services and Public Health-Legal Medicine Unit, University of Campania "Luigi Vanvitelli", via Luciano Armanni 5, 80138, Naples, Italy.
Pathology-Unit of Federico II University, via S. Pansini 3, 80131, Naples, Italy.
Publications dans "Vascularite du système nerveux central" :
Department of Radiology, Hospital of the University of Pennsylvania, 3400 Spruce Street, Philadelphia, PA, 19104, USA. jae.song@pennmedicine.upenn.edu.
Publications dans "Vascularite du système nerveux central" :
Glioblastoma (GBM) is an aggressive primary brain cancer. Lack of effective therapy is related to its highly invasive nature. GBM invasion has been studied with reductionist systems that do not fully ...
Non-tumor brain samples were obtained from patients undergoing surgery (n = 7). Organotypic brain slices were prepared, and green fluorescent protein (GFP)-labeled primary human GBM IDH-wild type cell...
After placement, cells migrated towards blood vessels; initially migrating with limited directionality, sending processes in different directions, and increasing their speed upon contact with the vess...
Human organotypic models can accurately study cell migration ex vivo. GBM IDH-wild type cells migrate toward the perivascular space in blood vessels and their migratory parameters change once they con...
The interaction among joints of the midtarsal complex and subtalar joint is important for locomotor function; however, its complexity poses substantial challenges in quantifying the joints' motions. W...
From industrial exoskeletons to implantable medical devices, robots that interact closely with people are poised to improve every aspect of our lives. Yet designing these systems is very challenging; ...
Inspired by foundational studies in classical and quantum physics, and by information retrieval studies in quantum information theory, we prove that the notions of 'energy' and 'entropy' can be consis...
Industry 4 (I4) was a revolutionary new stage for technological progress in manufacturing which promised a new level of interconnectedness between a diverse range of technologies. Sensors, as a point ...
As the global population rapidly ages with longer life expectancy and declining birth rates, the need for healthcare services and caregivers for older adults is increasing. Current research envisions ...
Bowers et al. express skepticism about deep neural networks (DNNs) as models of human vision due to DNNs' failures to account for results from psychological research. We argue that to fairly assess DN...
Humans can easily perform various types of hugs in human contact and affection experience. With the prevalence of robots in social applications, they would be expected to possess the capability of hug...
All human groups are equally human, but are they automatically represented as such? Harnessing data from 61,377 participants across 13 experiments (six primary and seven supplemental), a sharp dissoci...
Allogeneic stem cell transplantation (alloSCT) can be curative for hemato-oncology patients due to effective graft-versus-tumor immunity. However, relapse remains the major cause of treatment failure,...